PlainRecalls
FDA Drug Moderate Class II Terminated

AVKARE Ranitidine Hydrochloride Capsules 300 mg 500 Capsules Rx Only NDC 42291-736-50 UPC 342291736504 Manufactured for: AvKARE, Inc. Pulaski, TN 38478

Reported: November 6, 2019 Initiated: October 17, 2019 #D-0165-2020

Product Description

AVKARE Ranitidine Hydrochloride Capsules 300 mg 500 Capsules Rx Only NDC 42291-736-50 UPC 342291736504 Manufactured for: AvKARE, Inc. Pulaski, TN 38478

Reason for Recall

CGMP Deviations: Impurity N-nitrosodimethylamine (NDMA) found in API

Details

Recalling Firm
AVKARE Inc.
Units Affected
1351 bottles
Distribution
CO, MO
Location
Pulaski, TN

Frequently Asked Questions

What product was recalled?
AVKARE Ranitidine Hydrochloride Capsules 300 mg 500 Capsules Rx Only NDC 42291-736-50 UPC 342291736504 Manufactured for: AvKARE, Inc. Pulaski, TN 38478. Recalled by AVKARE Inc.. Units affected: 1351 bottles.
Why was this product recalled?
CGMP Deviations: Impurity N-nitrosodimethylamine (NDMA) found in API
Which agency issued this recall?
This recall was issued by the FDA Drug on November 6, 2019. Severity: Moderate. Recall number: D-0165-2020.